JPS57136529A - Immunogloblin composite body - Google Patents

Immunogloblin composite body

Info

Publication number
JPS57136529A
JPS57136529A JP57002635A JP263582A JPS57136529A JP S57136529 A JPS57136529 A JP S57136529A JP 57002635 A JP57002635 A JP 57002635A JP 263582 A JP263582 A JP 263582A JP S57136529 A JPS57136529 A JP S57136529A
Authority
JP
Japan
Prior art keywords
immunoglobulin
immunogloblin
composite body
fragment
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57002635A
Other languages
English (en)
Inventor
Fuaadeinando Rourando Jiyooji
Jiyooji Shiimonzu Robin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of JPS57136529A publication Critical patent/JPS57136529A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57002635A 1981-01-12 1982-01-11 Immunogloblin composite body Pending JPS57136529A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (1)

Publication Number Publication Date
JPS57136529A true JPS57136529A (en) 1982-08-23

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57002635A Pending JPS57136529A (en) 1981-01-12 1982-01-11 Immunogloblin composite body

Country Status (27)

Country Link
EP (1) EP0056322B1 (ja)
JP (1) JPS57136529A (ja)
KR (1) KR860001149B1 (ja)
AT (1) ATE16603T1 (ja)
AU (1) AU549495B2 (ja)
BG (1) BG40318A3 (ja)
CA (1) CA1180660A (ja)
CS (1) CS235525B2 (ja)
DD (1) DD201447A5 (ja)
DE (1) DE3267474D1 (ja)
DK (1) DK5982A (ja)
EG (1) EG15599A (ja)
ES (1) ES508633A0 (ja)
FI (1) FI820020L (ja)
GB (1) GB2090837B (ja)
GR (1) GR75182B (ja)
HU (1) HU186025B (ja)
IE (1) IE52239B1 (ja)
IL (1) IL64722A (ja)
MX (1) MX7215E (ja)
NZ (1) NZ199421A (ja)
PH (1) PH18031A (ja)
PL (1) PL128529B1 (ja)
PT (1) PT74252B (ja)
RO (1) RO82758B (ja)
SU (1) SU1069628A3 (ja)
ZA (1) ZA82122B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02152992A (ja) * 1988-02-08 1990-06-12 Ire Celltarg Sa Ｃ―３位に脂肪鎖を有するビンカ誘導体の複合体

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
ATE57187T1 (de) * 1983-03-30 1990-10-15 Lilly Industries Ltd Vincaleukoblastin-derivate.
GR79899B (ja) * 1983-03-30 1984-10-31 Lilly Industries Ltd
HUT34212A (en) * 1983-04-29 1985-02-28 Omnichem Sa Process for the production of new vindblastin conjugates
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
FI860456A (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
JPS5470384A (en) * 1977-08-22 1979-06-06 Inst Obu Kiyansaa Risaachi Roi High molecular complex
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02152992A (ja) * 1988-02-08 1990-06-12 Ire Celltarg Sa Ｃ―３位に脂肪鎖を有するビンカ誘導体の複合体

Also Published As

Publication number Publication date
EP0056322B1 (en) 1985-11-21
GB2090837B (en) 1984-07-18
IL64722A (en) 1985-07-31
SU1069628A3 (ru) 1984-01-23
IE820023L (en) 1982-07-12
PT74252A (en) 1982-02-01
FI820020L (fi) 1982-07-13
DK5982A (da) 1982-07-13
CS235525B2 (en) 1985-05-15
RO82758B (ro) 1984-01-30
ZA82122B (en) 1983-07-27
IE52239B1 (en) 1987-08-19
CA1180660A (en) 1985-01-08
ES8304149A1 (es) 1983-02-16
PL128529B1 (en) 1984-02-29
IL64722A0 (en) 1982-03-31
GR75182B (ja) 1984-07-13
PL234695A1 (ja) 1982-07-19
DE3267474D1 (en) 1986-01-02
MX7215E (es) 1988-01-08
RO82758A (ro) 1984-01-14
BG40318A3 (en) 1986-11-14
AU7927482A (en) 1982-07-22
ES508633A0 (es) 1983-02-16
NZ199421A (en) 1984-08-24
AU549495B2 (en) 1986-01-30
GB2090837A (en) 1982-07-21
PT74252B (en) 1983-08-24
ATE16603T1 (de) 1985-12-15
KR830008684A (ko) 1983-12-12
HU186025B (en) 1985-05-28
EG15599A (en) 1986-06-30
PH18031A (en) 1985-03-06
EP0056322A1 (en) 1982-07-21
DD201447A5 (de) 1983-07-20
KR860001149B1 (ko) 1986-08-18

Similar Documents

Publication Publication Date Title
JPS57136529A (en) Immunogloblin composite body
AU7366687A (en) Coupling agents for radiolabeling proteins
EP0205326A3 (en) Antibody conjugates
GR1000712B (el) Νεα αντισωματα που αντιδρουν με τα ανθρωπινα καρκινωματα.
DK0462145T3 (da) Covalente konjugater mellem lipid og oligonucleotid
NZ511956A (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
DE69128791D1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
DE3372175D1 (en) Covalent conjugates of an enzyme and an antibody, and medicinal compositions containing these conjugates
DE68923291T2 (de) Antikörper-konjugate mit zwei oder mehr kovalent vernetzten fc-regionen.
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
IL71366A (en) Immunoglobulin conjugates with vincaleukoblastine derivatives,their production and pharmaceutical compositions containing them
HU9302309D0 (en) Process for producing conjugates of bicyclo-polyaza-macrocyclo-carboxylic acid complexes and contrast-materials containing them
IL79260A (en) Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies
IE853071L (en) Immunotoxin
DE69228869D1 (de) Stabilisierte antikörperfragmente
RU93053897A (ru) Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения